• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-05-09

  This study introduces a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating high potency, metabolic stability, and therapeutic efficacy in metabolic, allergic, and oncological disease models. These findings provide a validated scaffold for future drug development targeting metabolic dysregulation.

• Bradykinin B2 Receptors Modulate Peristalsis in Guinea Pig I

  2026-05-08

  This study provides the first direct evidence that bradykinin, via B2 receptor activation, inhibits the peristaltic reflex in the guinea pig ileum. The findings clarify the receptor-specific mechanisms underlying gastrointestinal motility and have practical implications for ACE inhibition research and drug development.

• Low-Cost OP-DLP Enables High-Throughput 96-Well Hydrogel Pri

  2026-05-08

  This study presents an open-platform digital light printer (OP-DLP) capable of precise, reproducible hydrogel fabrication and spatial biomolecule activation in a 96-well format. Its affordability and flexibility address limitations of existing methods, enabling advanced applications in biomaterials and cell signaling research.

• Hoechst 33342 Nuclear Stain: Advanced Workflows & Optimizati

  2026-05-07

  Hoechst 33342 Solution (1 mg/mL) from APExBIO delivers high-fidelity, low-cytotoxicity nuclear staining for both live and fixed cell applications. This article unpacks bench-proven protocols, integration with senescence research, and pragmatic troubleshooting for maximizing data quality in fluorescence microscopy and flow cytometry.

• Imeglimin Enhances Mitochondrial Function in CTS Subsynovial

  2026-05-07

  This study demonstrates that Imeglimin significantly improves mitochondrial function in subsynovial connective tissue (SSCT) cells from patients with idiopathic carpal tunnel syndrome. The findings highlight mitochondrial dysfunction as a key contributor to CTS pathology and suggest mitochondrial-targeted interventions as a promising therapeutic avenue.

• Cholesterol Impairs Lipid Nanoparticle Intracellular Traffic

  2026-05-06

  This study reveals that elevated cholesterol content in lipid nanoparticles (LNPs) leads to their aggregation in peripheral early endosomes, hindering effective intracellular trafficking and nucleic acid delivery. The research introduces a streptavidin–biotin-DNA tracking strategy, providing mechanistic insight into how LNP composition influences delivery efficiency.

• Perospirone (SM-9018 Free Base): Optimizing Neuropsychiatric

  2026-05-06

  Perospirone (SM-9018 free base) bridges advanced schizophrenia research and vascular pharmacology with dual receptor and Kv1.5 channel modulation. This guide empowers researchers to streamline experimental workflows, troubleshoot real-world challenges, and maximize the translational impact of their findings.

• Verteporfin in Applied Research: Protocols, Performance & Tr

  2026-05-05

  Verteporfin, also known as CL 318952, is redefining experimental design in photodynamic therapy and autophagy research. This article delivers data-driven workflows, troubleshooting strategies, and protocol benchmarks to maximize your results using APExBIO's trusted Verteporfin.

• LDN-193189: Elevating BMP Pathway Inhibition for Neurovirolo

  2026-05-05

  Explore how LDN-193189, a potent ALK inhibitor, advances BMP signaling pathway research in both neurovirology and epithelial barrier studies. This article uniquely dissects mechanistic insights and practical assay decisions not covered elsewhere.

• Canagliflozin Hemihydrate: Advanced Mechanistic Insights for

  2026-05-04

  Explore the nuanced role of Canagliflozin hemihydrate in glucose metabolism research. This article delivers a deeper mechanistic analysis, new assay decision frameworks, and evidence-based guidance distinct from existing resources.

• Applied FK866 (APO866) Workflows in Hematologic Cancer Resea

  2026-05-04

  FK866 (APO866) enables precise, reproducible targeting of NAD metabolism in hematologic malignancy research. This guide details advanced protocols, troubleshooting insights, and key innovations—drawing on both landmark and recent studies—to empower robust experimental design.

• Streptavidin-FITC: Precision Fluorescent Detection in Biotin

  2026-05-03

  Streptavidin-FITC from APExBIO delivers unrivaled sensitivity for biotin detection across immunohistochemistry, flow cytometry, and nanoparticle trafficking assays. This guide translates the latest workflow advances and troubleshooting insights—directly informed by cutting-edge research—into practical protocols for robust, reproducible fluorescence labeling.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocols & QC Guid

  2026-05-02

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody streamlines detection of rabbit primary antibodies in immunoassays such as Western blot, ELISA, and IHC by providing high specificity and robust signal amplification. This reagent is not intended for diagnostic or clinical use and should not be substituted in workflows requiring monoclonal or subclass-specific detection.

• Transmission Dynamics of Carbapenemase Genes in CREC: Insigh

  2026-05-01

  This study systematically characterizes carbapenemase-encoding gene (CEG) prevalence and transmission in carbapenem-resistant Enterobacter cloacae (CREC) across eight hospitals in Guangdong, China (2022–2024). It reveals high rates of plasmid- and chromosome-borne CEGs, predominant blaNDM-1 carriage, robust horizontal gene transfer, and multidrug resistance—all of which have direct implications for antibiotic resistance research and clinical surveillance.

• BX795: A Potent PDK1 Inhibitor for Cancer and Immunity

  2026-05-01

  BX795 is a highly selective PDK1 inhibitor with nanomolar potency, also targeting TBK1 and IKKε. It blocks IRF3-driven interferon-β production and demonstrates robust inhibition of tumor cell growth in vitro. BX795 is widely applied in kinase assays and cancer research workflows.

14577 records 1/972 page Next 12345 下5页 Last page